The first case concerned a 37 year old anti-HCV negative patient, attempting intracytoplasmic sperm injection (ICSI) for assisted reproductive technologies have accepted HCV positive patients into their programmes. We report in the male infertility. She had a twin pregnancy and presented with clinical acute hepatitis during the fourth month of gestation, present paper two cases of undoubted patient to patient HCV transmission while patients were attending for with an increase in liver transaminases. Serum examination showed the presence of anti-HCV antibodies as well as HCV assisted conception. In both cases, HCV genotyping and sequencing of the first hypervariable region of the HCV RNA. The pregnancy had a favourable evolution with a decrease in transaminase concentrations and resulted in the genome provided molecular evidence for nosocomial transmission. Investigations made to elucidate the route of birth of two healthy boys. The search for HCV RNA was negative in the newborns and remained negative after 18 contamination have shown that the most likely route of contamination is through healthcare workers. Such months of life. The patient remained HCV RNA positive 2 months after delivery. Since liver biopsy showed signs of nosocomial HCV infection has been reported in other healthcare situations, mainly in dialysis units, and physical severe hepatitis, the patient was treated by α-interferon, 3ϫ10 6 units twice a week, for 11 months. The transaminases then proximity was also suspected to be at the origin of the infection. We conclude that assisted reproduction teams returned to normal and HCV RNA remained undetectable after treatment interruption with a follow-up of 6 months. must be very prudent when including such patients in their programmes.
Introduction bodies and confirmed by the presence of HCV RNA in serum. Since she was not pregnant, the patient was immediately More and more patients infected by the hepatitis C virus (HCV) attempt IVF, raising the question of virus transmission.
treated by α-interferon, 3ϫ10 6 units twice a week for 6 months after which HCV RNA disappeared from her serum. The risk of mother to child transmission of HCV has been well studied and appears to be low (MacDonald et al., 1996;  Since these two patients were negative for anti-HCV antibodies at the time of their attempts at assisted reproduction and Van der Poel and Ebeling, 1998) , so that teams involved in assisted reproductive technologies have agreed to include such did not present any risk factors (blood transfusion, endoscopy, piercing, etc.) we suspected a nosocomial transmission in the patients in their programmes (Fédération des BLEFCO, 1997) . However, nosocomial infections have been reported despite course of the various procedures carried out during assisted reproduction treatment. We investigated the patients' records no clear evidence of the route of contamination. A French study, including 6664 patients with chronic hepatitis C, revealed and the procedures used during these attempts. We found that each of them was treated concomitantly, but at different periods that 37% of contamination is due to blood transfusion and 15% to another nosocomial origin (Roudot Thoraval et al., (one in May 1997 , the other in September 1997 , at the same time as a patient known to be HCV infected. In both cases 1997). Moreover, viruses transmissions have been reported after percutaneous exposure to blood and blood-derived the contaminated patient had follicular puncture immediately after the infected one. The HCV genotypes from the three products in healthcare workers (Howard et al., 1997) . These . Neighbour-joining phylogenetic tree analysis comparing nucleotide sequences in the E2 gene encompassing the first hypervariable region in HCV genotype 1b strains from the three patients attending the IVF centre (case 1, case 2, source patient), local controls (BRO, DOS, LIM, PEY, RIO, BRU, AJ007975, Y15538, Y15551, Y15533, Y15542, Y15546, Y15545) and controls from the EMBL data bank (HCVJ, HCVJ4, D10750, D01217, AJ238799, AJ1329997, M58335, D01171, X61596, D00009, D30613, AF16504, U45476). All sequences from the two newly infected patients and the sequence from the already infected patient, i.e. source patient attending the IVF centre, clustered together in a monophyletic nest (circled). The number given at the branch point indicates the frequency with which the node occurred out of 100 bootstrap replicates.
patients, characterized by the line probe assay (LIPA HCVII ® ; the assisted reproduction attempts shared by patients. Follicular growth was monitored by daily vaginal ultrasonography and Innogenetics, Zwijndrecht, Belgium), were 1b. Two-strand serum oestradiol measurement. Ultrasonography is unlikely to direct sequencing was carried out on a nested polymerase be contaminating since probes were covered with a protective chain reaction (PCR) product in the E2 gene encompassing sheath and wiped after each patient with germicidal disposable the hypervariable region 1 of the HCV genome as previously cloths, which has been reported to be effective in the prevention described (Izopet et al., 1999) . Phylogenetic analysis of E2 of virus transmission (Milki and Fisch, 1998) . Moreover, no sequences from these 1b strains and a control panel consisting other patient monitored during the same period has been of 1b strains from the same geographical area plus 1b strains infected. extracted from the EMBL (EMBL-European Bio-Informatics Contamination during the follicle puncture itself seems also Institute) data bank indicated clustering of the two cases of to be unlikely. Indeed, contaminating and contaminated patients de-novo infections with the already infected patient attending were punctured in different rooms, with different probes and the IVF centre (Figure 1 ). We screened all other patients all other materials were disposable. This situation looks like treated in the same periods (sharing same days of puncture, the one reported in dialysis centres, where patients treated on ultrasonographic examinations and blood sampling) for antidifferent but adjacent machines were contaminated by the HCV antibodies and none of them appeared to be infected. same viruses (Natov and Pereira, 1996 ; Pereira and Levey, Moreover, all the staff of the assisted reproduction treatment 1997; Ouzan, 1997) . Therefore a physical proximity during centre (physicians, biologists, nurses, etc.) were tested and routine health care appears to be a risk of HCV transmission. found to be negative. Follicular puncture was therefore not This risk seems to be linked to percutaneous exposure during suspected as the cause of contamination. Moreover, the contami.v. injection processes or to the use of multi-dose vials of inated patients and the suspected contaminating one underwent drugs (MacDonald et al., 1996; Pereira and Levey, 1997 ; follicular puncture in different rooms, with different probes Couzigou, 1997) . Cross-infection between patients has been and single use materials, the follicular fluids were treated reported in a care unit where nurses did not change their in different laminar hoods and oocytes placed in different gloves but disinfected them with alcohol-based products, incubators. These findings led us to postulate that the contaminactive on HCV viruses (Schvarcz et al., 1996 ; Van der Poel ination occurred outside the direct practice of IVF, and possibly and Ebeling, 1998) . The use of multi-dose vials of heparin through procedures practised by ancillary staff.
has also been shown to be a route of contamination in dialysis patients (Pereira and Levey, 1997) .
Discussion
Laboratory contamination by hepatitis B has been reported Before concluding that the virus has been transmitted via due to the use of serum containing culture medium (Quint et al., 1994) . This cannot be the case in our team since proteinhealth workers, we have carefully investigated each step of free media without any supplementation are used for IVF (Parinaud et al., 1998 (Parinaud et al., , 1999 . Moreover, the laboratory instruments used for follicular fluid examination, IVF and embryo culture were different.
Contamination during embryo transfer is unlikely since it is not bloody, only disposable materials were used and no i.v. injection was done.
Patients with anti-HCV antibodies are now included in our programme only if HCV RNA is negative at the beginning of the IVF cycle. French law includes guidelines concerning assisted reproduction procedures, published in February 1999 (Ministère de l'Emploi et de la Solidarité, 1999) . Assisted reproduction treatment in HCV positive patients (male or female partner) is possible only in the case of a clinical research protocol accepted by the governmental health ministry. However, these measures are mainly made to protect against partner to partner and mother to child contamination and not for nosocomial transmissions. Our experience leads us to recommend extreme prudence and to take all possible hygienic precautions when including such patients in an IVF programme. A way to minimize the risks could be to treat these patients before IVF in order to eradicate the virus.
